AtroPen Alternatives Compared
| AtroPen (atropine) | Atropine | Hyoscyamine |
|
|---|
| AtroPen (atropine) | Atropine | Hyoscyamine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Bradyarrhythmia, AV Heart Block, Anticholinesterase Poisoning. AtroPen may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Bradyarrhythmia, AV Heart Block, Anticholinesterase Poisoning, Organophosphate Poisoning. Atropine may also be used for purposes not listed in this medication guide. |
Prescription only
Hyoscyamine may be used in the treatment of a wide variety of gastrointestinal problems including cramps, bladder control issues, and irritable bowel syndrome. Drowsiness and dry mouth are common... View more |
||||||||||||||||||||||||
| More about AtroPen (atropine) | More about Atropine | More about Hyoscyamine | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
Atropine has an average rating of 3.0 out of 10 from a total of 2 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 100% reported a negative effect. |
Hyoscyamine has an average rating of 7.8 out of 10 from a total of 113 ratings on Drugs.com. 73% of reviewers reported a positive effect, while 15% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all AtroPen prices |
View all Atropine prices |
View all Hyoscyamine prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
|
N/A |
AtroPen | Anaspaz, Ed-Spaz, Hyosyne, Levbid, Levsin, Levsin SL, NuLev, Oscimin, Symax Duotab, Symax SL, Symax SR View more | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
4.3 hours |
4.3 hours |
4 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 219 drugs are known to interact with AtroPen:
|
A total of 219 drugs are known to interact with Atropine:
|
A total of 207 drugs are known to interact with Hyoscyamine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
May 15, 1973 |
May 15, 1973 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.